QA: Cormedix Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001410098_2023_Cormedix_Inc.pdf

Logs

Graph

Absolute values for 0001410098, Cormedix Inc

  xvar xval
0 AssetsCurrent 59,551,175
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,609,679
3 remainder_Assets 877,405
4 LiabilitiesCurrent 6,310,891
5 LiabilitiesNoncurrent 667,632
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold -206,554
8 SellingGeneralAndAdministrativeExpense 16,335,667
9 ResearchAndDevelopmentExpense 12,725,455
10 remainder_Expenses -361,144
11 remainder_Revenues 149,861
12 remainder_NetIncome 254,805
13 remainder_ComprehensiveNetIncome -3,282
  yvar yval
0 Assets 62,038,259
1 Liabilities 6,978,523
2 Expenses 28,493,424
3 Revenues 149,861
4 StockholdersEquity 55,059,736
5 NetIncome -28,088,758
6 ComprehensiveNetIncome -28,090,399
7 BaseVar 48,959,077
8 EconomicCapitalRatiobeforeLimitedLiability 2.66
9 EconomicCapitalRatio 3.46

Edgar->Model Mapping

Feature Distribution

Change over Time